News

View our latest research stories.

March 8, 2024 Collaborations

Back in Person and Taking a Bite of the Big Apple

Over the course of three days, from October 18-20, 2023, the annual Addiction Health Services Research (AHSR) Conference brought over 300 attendees to Roosevelt Island in New York City to share new addiction research findings, learn about the field through pre-conference workshops, develop collaborative relationships, and support early-career and under-represented investigators. “I am so proud […]

Grid image of moderators and speakers who took part in the convening.
February 8, 2024 Collaborations

Incentivizing Recovery: Payment, Policy, and Implementation of Contingency Management

On January 19th, 2024, CHERISH and the University of Pennsylvania’s Leonard Davis Institute of Health Economics (LDI), co-hosted a virtual convening titled Incentivizing Recovery: Payment, Policy, and Implementation of Contingency Management. Contingency management is a proven and promising treatment for specific substance use disorders, especially stimulant use disorder. However, significant gaps in knowledge regarding the […]

February 16, 2023 Collaborations

Will States and Counties Spend Their National Opioid Settlements Effectively?

As $54 billion in National Opioid Settlement funds begin moving out toward states, counties, and municipalities, there is widespread concern among health authorities that the legal victory does not become a repeat of the 1998 mega-billion-dollar Tobacco Master Settlement Agreement fiasco in which most states used the money for just about everything except tobacco cessation […]

March 17, 2022 Collaborations

Why Does the Opioid Mortality Rate Continue to Rise?

From April 2020 through April 2021, there were 100,300 drug overdose deaths across the country according to the CDC — a 28.5% increase over the previous year. Some 75% of these were opioid-related overdoses that killed an average of nine users an hour around the clock throughout the year. Looking forward, the just-published Stanford-Lancet Commission on […]

February 2, 2022 Policy Watch

Advancing Evidence-Based Substance Use Disorder Treatment Policies

If you want to reform state laws to require detox facilities to include medications like buprenorphine and methadone in their treatments, you should start by changing the “hearts and minds” of those who oppose it, Rebekah Gee, MD, MPH, MHSPR, told the January 14, 2022 Penn LDI/CHERISH Virtual Conference at the University of Pennsylvania. Keynoting a gathering organized […]

January 31, 2022 Collaborations

Principles and Metrics for Evaluating Oregon’s Drug Decriminalization Measure

In November 2020, Oregonians voted to pass Measure 110, a ballot initiative that decriminalizes the possession of small amounts of all drugs and increases access to low-barrier substance use disorder treatment and harm reduction services. Led by the Drug Policy Alliance, the ballot measure is a historic step forward to address drug-related arrests that disproportionally impact low-income and people of […]

December 9, 2021 Collaborations

Improving Opioid Overdose

In the summer of 2021, the National Institute on Drug Abuse (NIDA) awarded Bruce R. Schackman, CHERISH director and Saul P. Steinberg Distinguished Professor at Weill Cornell Medicine, and Natasha Martin, CHERISH Research Affiliate and associate professor in the Department of Medicine at the University of California San Diego, a scientific conference grant to provide simulation modeling […]

April 14, 2020 Collaborations

In Conversation with Jules Netherland and Daniel Raymond: Engaging Health Economics and Health Services Researchers with Harm Reduction Policymakers and Advocates

When it comes to substance use disorder-related policies and funding, evidence is absolutely necessary though not sufficient. In a recent webinar with CHERISH Research Affiliates, Dr. Jules Netherland, Managing Director of the Drug Policy Alliance Department of Research and Academic Engagement, and Daniel Raymond, Deputy Director of Planning and Policy at the Harm Reduction Coalition, discussed the potential roles […]

September 11, 2019 Collaborations

Achieving Value in Substance Use Disorder Treatment: Paying for What Works (and Not Paying for What Doesn’t): Workshop Summary

More than 100 policymakers, practitioners, and researchers discussed and debated how payment policy can promote evidence-based, cost-effective substance use disorder treatment, in a recent workshop hosted by the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV and HIV (CHERISH) and the Leonard Davis Institute of Health Economics at the University of […]

June 14, 2017 Policy Watch

CHERISH Conference on Substance Use Disorder Treatment Research

In the opening plenary panel of the CHERISH (Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV and HIV) conference on evidence-based policy and practice are (l to r) Daniel Polsky, PhD, moderator and Executive Director of the University of Pennsylvania’s Leonard Davis Institute of Health Economics (LDI); Tom McLellan, PhD, Chairman of the Board and […]

Engage with CHERISH

Submit a Consultation Request or Contact Us to learn more about how CHERISH can support your research or policy goals.